Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Transcription-coupled nucleotide excision repair (TC-NER) complex is a specialized DNA repair assembly that prioritizes the removal of helix-distorting lesions from the transcribed strands of active genes (Marteijn et al., 2014, Nature Reviews Molecular Cell Biology). This process is triggered when RNA polymerase II (Pol II) encounters DNA damage, such as UV-induced photoproducts or bulky chemical adducts, and becomes physically stalled (Spivak, 2015, Archives of Toxicology). The stalled polymerase complex serves as a signal to recruit key TC-NER factors, including the Cockayne Syndrome proteins CSB (ERCC6) and CSA (ERCC8), which subsequently recruit the TFIIH complex and endonucleases to excise the damage (Vermeulen & Fousteri, 2013, Cold Spring Harbor Perspectives in Biology). In oncology, the TC-NER pathway is a critical determinant of resistance to platinum-based chemotherapies, as it efficiently removes the DNA cross-links these drugs induce (Damia & Broggini, 2014, Frontiers in Oncology). Conversely, genetic deficiencies in TC-NER components lead to severe disorders like Cockayne syndrome, characterized by growth failure, neurodegeneration, and premature aging (Gregersen & Svejstrup, 2012, Frontiers in Genetics). Therapeutic strategies often focus on inhibiting components of this complex, such as using spironolactone to degrade the XPB subunit of TFIIH, to sensitize cancer cells to DNA-damaging agents (Alekseev et al., 2014, Nature Communications).
Recognition and excision of DNA lesions on the transcribed strand of active genes, initiated by stalled RNA polymerase II.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription-coupled nucleotide excision repair complex (TC-NER complex) (TC-NER).